You are here

DISPOSABLE INSTRUMENTATION FOR THE DIAGNOSIS OF DISEASES OF MILITARY IMPORTANCE

Award Information
Agency: Department of Defense
Branch: Army
Contract: N/A
Agency Tracking Number: 3646
Amount: $46,377.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1986
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
11760 Sorrento Valley Rd - Ste
San Diego, CA 92121
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 JON C WANNLUND
 (619) 455-9283
Business Contact
Phone: () -
Research Institution
N/A
Abstract

THE PRIMARY OBJECTIVES OF THIS PROJECT ARE TO DEVELOP A RAPID SENSITIVE, AND PORTABLE DETECTION SYSTEM BY USING BIOLUMINESCENCE AS THE LABEL FOR THE IDENTIFICATION OF DISEASE-CAUSING AGENTS AS WELL AS THE DIAGNOSIS OF DISEASE. BIOLUMINESCENT LABELS WHEN LINKED TO THE TARGETING AGENT (I.E. MONOCLONAL ANTIBODIES OR DNA PROBES) OFFER EXTREME SENSITIVITY IN DETECTION AND THE ABILITY TO MONITOR AND MEASURE THE ASSAY WITH SMALL, LOW COST, PORTABLE DEVICES. AFTER IDENTIFYING THE AGENTS TO BE DETECTED, THE BIOLUMINESCENT DETECTION SYSTEM IS COVALENTLY ATTACHED TO THE BEST TARGETING AGENT THAT WILL GIVE SPEED AND SENSITIVITY. OPTIMIZATION OF THE TEST SYSTEM WILL REQUIRE DETERMINING THE BEST COVALENT LINKAGE FOR THE BIOLUMINESCENT LABEL TO THE TARGETING AGENT AND THE BEST CONCENTRATION OF REAGENTS TO PROMOTE SPEED AND SENSITIVITY. THE SPECIMEN FLUID USED WILL DICTATE THE SYSTEM'S APPROACH TO DETECTING THE DESIRED AGENT.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government